High Mobility Group A2 protects cancer cells against telomere dysfunction

por Natarajan, Suchitra, Begum, Farhana, Gim, Jeonga, Wark, Landon, Henderson, Dana, Davie, James R., Hombach-Klonisch, Sabine, Klonisch, Thomas
Publicado 2016

HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy

por Summer, Heike, Li, Ou, Bao, Qiuye, Zhan, Lihong, Peter, Sabrina, Sathiyanathan, Padmapriya, Henderson, Dana, Klonisch, Thomas, Goodman, Steven D., Dröge, Peter
Publicado 2009